Advertisement

Multi-Resistant Gram-Negative Bacilli: Impact of Antibiotic Restriction

  • P. Toltzis
Conference paper
Part of the Topics in Anaesthesia and Critical Care book series (TIACC)

Abstract

Infections with gram-negative bacilli that are resistant to one or more classes of parenteral antibiotics have become increasingly common over the past decade [1]. These bacteria express resistance to the broad-spectrum b-lactam agents, amino-glycosides, or quinolones through different molecular mechanisms, which may coexist within the same organism. They are isolated most frequently in large teaching hospitals [2] and are commonly found in intensive care units (ICU) [3, 4]. Indeed, since broad-spectrum antibiotics are disproportionately used in the ICU, it is widely held that many of these organisms originate there. This has generated considerable interest in testing antibiotic utilization policies for hospitals in general, and the ICU in particular, designed to lower the incidence of colonization or infection with antibiotic-resistant gram-negative bacteria [5, 6]. This chapter will describe two of these policies and the data supporting their effectiveness.

Keywords

Intensive Care Unit Clin Infect Resistant Organism Aminoglycoside Resistance Antibiotic Restriction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    L Burwen DR, Banerjee SN, Gaynes RP et al (1994) Ceftazidime resistance among selected gram-negative bacilli in the United States. J Infect Dis 170: 1622–1625PubMedCrossRefGoogle Scholar
  2. 2.
    Itokazu GS, Quinn JP, Bell-Dixon C et al (1996) Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 23: 779–784PubMedCrossRefGoogle Scholar
  3. 3.
    Archibald L, Phillips L, Monnett D et al (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 24: 211–215PubMedCrossRefGoogle Scholar
  4. 4.
    Gaynes R (1997) The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infecti Dis Clin of North Am 11: 757–765CrossRefGoogle Scholar
  5. 5.
    Rice LB, Toltzis P (1997) Antibiotic use and resistance in the intensive care unit. Curr Opin Crit Care 3: 348–354Google Scholar
  6. 6.
    Cunha BA (1998) Antibiotic resistance. Crit Care Clin 14: 309–327PubMedCrossRefGoogle Scholar
  7. 7.
    McGowan JE (1987) Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull NY Acad Med 63: 253–268Google Scholar
  8. 8.
    Toltzis P, Blumer JL (1995) Antibiotic-resistant gram-negative bacteria in the critical care setting. Pediatr Clin North Am 42: 687–702PubMedGoogle Scholar
  9. 9.
    Price DJE, Sleigh JD (1970) Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet 2: 1213–1215PubMedCrossRefGoogle Scholar
  10. 10.
    Meyer KS, Urban C, Eagan JA et al (1993) Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119: 353–358PubMedCrossRefGoogle Scholar
  11. 11.
    Rice LB, Eckstein EC, DeVente J, Shlaes DM (1996) Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 23: 118–124PubMedCrossRefGoogle Scholar
  12. 12.
    Chow JW, Fine MJ, Shales DM et al (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115: 585–590PubMedCrossRefGoogle Scholar
  13. 13.
    Jacobson KL, Cohen SH, Inciardi JF (1995) The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group 1 13-lactamaseproducing organisms. Clin Infect Dis 21: 1107–1113PubMedCrossRefGoogle Scholar
  14. 14.
    Medeiros AA (1997) Evolution and dissemination of 13-lactamases accelerated by generations of, (3-lactam antibiotics. Clin Infect Dis 24 [Suppl 1]: S19 - S45PubMedCrossRefGoogle Scholar
  15. 15.
    Jessop AB, John JF, Paul SM (1998) Risk factors associated with the acquisition of amikacin-resistant gram-negative bacilli in Central New Jersey hospitals. Infect Control Hosp Epidemiol 19: 186–188PubMedCrossRefGoogle Scholar
  16. 16.
    King JW, White MC, Todd JR, Conrad SA (1992) Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. Clin Infect Dis 14: 908–915PubMedCrossRefGoogle Scholar
  17. 17.
    Gerding DN, Larson TA (1985) Aminoglycoside resistance in gram-negative bacilli during increased amikacin use: comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center. Amer J Med 79 [Suppl IA]: 1–7PubMedCrossRefGoogle Scholar
  18. 18.
    Gerding DN, Larson TA, Hughes RA et al (1991) Aminoglycoside resistance and amino-glycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 35: 1284–1290PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Kollef MH, Vlasnik J, Sharpless L et al (1997) Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 156: 1040–1048PubMedGoogle Scholar
  20. 20.
    Talon D, Capellier G, Boillot A, Michel-Briand Y (1995) Use of pulsed-field gel elec-trophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit. Intensive Care Med 21: 996–1002PubMedCrossRefGoogle Scholar
  21. 21.
    Berkowitz FE, Metchock B (1955) Third generation cephalosporin-resistant gram-negative bacilli in the feces of hospitalized children. Pediatr Infect Dis J 14: 97–100CrossRefGoogle Scholar
  22. 22.
    Carmeli Y, Samore MH (1997) Comparison of treatment with imipenem vs ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis 24: 1131–1134PubMedCrossRefGoogle Scholar
  23. 23.
    Toltzis P, Yamashita T, Vilt L, Blumer JL (1997) Colonization with antibiotic-resistant gram-negative organisms in a pediatric intensive care unit. Crit Care Med 25: 538–544PubMedGoogle Scholar
  24. 24.
    Toltzis P, Yamashita T, Morrisy A et al (1998) Antibiotic restriction in a pediatric intensive care unit does not decrease endemic colonization with antibiotic resistant organisms. Crit Care Med 26: 1893–1899.PubMedGoogle Scholar
  25. 25.
    Yuan M, Aucken H, Hall LMC et al (1998) Epidemiological typing of Klebsiellae with extended-spectrum ß-lactamases from European intensive care units. J Antimicrob Chemother 41: 527–539PubMedCrossRefGoogle Scholar
  26. 26.
    Jarlier V, Fosse T, Philippon A (1996) Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals ( ICU study ). Intensive Care Med 22: 1057–1065Google Scholar
  27. 27.
    D’Agata EMC, Venkataraman L, DeGirolami P et al (1999) Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med 276: 1090–1095Google Scholar
  28. 28.
    Toltzis P, Hoyen C, Spinner-Block S et al (1999) Factors that predict preexisting colonization with antibiotic-resistant gram-negative bacilli in patients admitted to a pediatric intensive care unit. Pediatrics 103: 719–723PubMedCrossRefGoogle Scholar
  29. 29.
    Monnet DL, Archibald LK, Phillips L et al (1998) Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Infect Control Hosp Epidemiol 19: 388–394PubMedCrossRefGoogle Scholar
  30. 30.
    Hammond JM, Potgieter PD, Forder AA, Plump H (1990) Influence of amikacin as the primary aminoglycoside on bacterial isolates in the intensive care unit. Grit Care Med 18: 607–610CrossRefGoogle Scholar
  31. 31.
    Shlaes DM, Gerding DN, John JF et al (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25: 584–99PubMedCrossRefGoogle Scholar
  32. 32.
    Niederman MS (1997) Is “crop rotation” of antibiotics the solution to a “resistant” problem in the ICU? Am J Respir Crit Care Med 156: 1029–1031PubMedGoogle Scholar
  33. 33.
    Goldie JH, Goldman AJ, Gudauskas GA (1982) Rationale for the use of alternating noncross-resistant chemotherapy. Cancer Treat Rep 66: 439–449PubMedGoogle Scholar
  34. 34.
    Rivera GK, Raimondi SC, Hancock ML et al (1991) Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337: 61–66PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2001

Authors and Affiliations

  • P. Toltzis

There are no affiliations available

Personalised recommendations